BTIG Maintains CareDx(CDNA.US) With Buy Rating, Maintains Target Price $40
Buy Rating Affirmed for CareDx: Leadership Enhancements and Undervalued Stock Present Growth Opportunities
Jefferies Initiates CareDx(CDNA.US) With Sell Rating, Announces Target Price $28
CareDx Initiated at Underweight by Wells Fargo
Wells Fargo Initiates Coverage On CareDx With Underweight Rating, Announces Price Target of $28
CareDx Price Target Announced at $40.00/Share by BTIG
CareDx Analyst Ratings
BTIG Upgrades CareDx(CDNA.US) to Buy Rating, Announces Target Price $40
Craig-Hallum Maintains CareDx(CDNA.US) With Buy Rating, Raises Target Price to $40
CareDx Analyst Ratings
Craig-Hallum Maintains CareDx(CDNA.US) With Buy Rating, Announces Target Price $32
H.C. Wainwright Keeps Their Hold Rating on CareDx (CDNA)
H.C. Wainwright Maintains CareDx(CDNA.US) With Hold Rating
CareDx Analyst Ratings
Goldman Sachs Maintains Buy on CareDx, Raises Price Target to $16
Nephron Initiates CareDx at Hold Rating With $15 Price Target
CaredX Inc.: Jefferies underwrites under a purchase rating assumption; target share price is $17 to $12
HC Wainwright & Co. : Reiterates CaredX (CDNA.US) neutral rating.
CareDx Analyst Ratings
CareDx (CDNA) Gets a Hold From H.C. Wainwright